Mycolic acids are complex, long-chain fatty acids that are a major component of the cell wall of Mycobacterium species, including the causative agents of tuberculosis and leprosy, providing them with unique characteristics such as resistance to acid-alkali stability, pigmentation, and protection against host immune responses.
A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts.
An order of gram-positive, primarily aerobic BACTERIA that tend to form branching filaments.
Toxic glycolipids composed of trehalose dimycolate derivatives. They are produced by MYCOBACTERIUM TUBERCULOSIS and other species of MYCOBACTERIUM. They induce cellular dysfunction in animals.
A genus of asporogenous bacteria that is widely distributed in nature. Its organisms appear as straight to slightly curved rods and are known to be human and animal parasites and pathogens.
A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation.
A thiosemicarbazone that is used in association with other antimycobacterial agents in the initial and continuation phases of antituberculosis regimens. Thiacetazone containing regimens are less effective than the short-course regimen recommended by the International Union Against Tuberculosis and are used in some developing countries to reduce drug costs. (From Martindale, The Extra Pharmacopoeia, 30th ed, p217)
A rapid-growing, nonphotochromogenic species of MYCOBACTERIUM originally isolated from human smegma and found also in soil and water. (From Dorland, 28th ed)
Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
A genus of gram-positive BACTERIA in the family Gordoniaceae, isolated from soil and from sputa of patients with chest disorders. It is also used for biotransformation of natural products.
Polysaccharides composed of repeating galactose units. They can consist of branched or unbranched chains in any linkages.
A genus of gram-positive, aerobic bacteria whose species are widely distributed and are abundant in soil. Some strains are pathogenic opportunists for humans and animals.
Cyclopropanes are a class of hydrocarbons characterized by a small ring structure containing three carbon atoms, each with single bonds to the other two carbons and to hydrogen atoms, making it highly strained and reactive, which has implications for its use as an anesthetic in medicine.
The outermost layer of a cell in most PLANTS; BACTERIA; FUNGI; and ALGAE. The cell wall is usually a rigid structure that lies external to the CELL MEMBRANE, and provides a protective barrier against physical or chemical agents.
So-called atypical species of the genus MYCOBACTERIUM that do not cause tuberculosis. They are also called tuberculoid bacilli, i.e.: M. buruli, M. chelonae, M. duvalii, M. flavescens, M. fortuitum, M. gilvum, M. gordonae, M. intracellulare (see MYCOBACTERIUM AVIUM COMPLEX;), M. kansasii, M. marinum, M. obuense, M. scrofulaceum, M. szulgai, M. terrae, M. ulcerans, M. xenopi.
A second-line antitubercular agent that inhibits mycolic acid synthesis.
The form of fatty acid synthase complex found in BACTERIA; FUNGI; and PLANTS. Catalytic steps are like the animal form but the protein structure is different with dissociated enzymes encoded by separate genes. It is a target of some ANTI-INFECTIVE AGENTS which result in disruption of the CELL MEMBRANE and CELL WALL.
A species of gram-positive, asporogenous, non-pathogenic, soil bacteria that produces GLUTAMIC ACID.
A saprophytic bacterium widely distributed in soil and dust and on plants.
Phenylthiourea is a chemical compound with the formula C6H5NCS, used historically in scientific research as an inhibitor of tyrosinase activity, but now mostly replaced by other more specific agents, and infrequently used in certain diagnostic tests or as a reagent in organic synthesis.
A 3-oxoacyl reductase that has specificity for ACYL CARRIER PROTEIN-derived FATTY ACIDS.
Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix.
Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed)
A species of bacterium of the family NOCARDIACEAE, producing pulmonary infections in man.
Constituent of 30S subunit prokaryotic ribosomes containing 1600 nucleotides and 21 proteins. 16S rRNA is involved in initiation of polypeptide synthesis.
A bacterial genus of the order ACTINOMYCETALES.
DNA sequences encoding RIBOSOMAL RNA and the segments of DNA separating the individual ribosomal RNA genes, referred to as RIBOSOMAL SPACER DNA.
Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.
A subclass of enzymes of the transferase class that catalyze the transfer of a methyl group from one compound to another. (Dorland, 28th ed) EC 2.1.1.
Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.
An enzyme of long-chain fatty acid synthesis, that adds a two-carbon unit from malonyl-(acyl carrier protein) to another molecule of fatty acyl-(acyl carrier protein), giving a beta-ketoacyl-(acyl carrier protein) with the release of carbon dioxide. EC 2.3.1.41.
The bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis.
Infections with bacteria of the genus MYCOBACTERIUM.
A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds.
Deoxyribonucleic acid that makes up the genetic material of bacteria.
The relationships of groups of organisms as reflected by their genetic makeup.
"Esters are organic compounds that result from the reaction between an alcohol and a carboxylic acid, playing significant roles in various biological processes and often used in pharmaceutical synthesis."
Diaminopimelic acid (DAP) is a crucial intermediate in the biosynthesis of L-lysine, an essential amino acid, and is also a significant component of peptidoglycan, a cell wall polymer in bacteria.
Proteins found in any species of bacterium.
An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers.
Any compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic moiety such as an acylglycerol (see GLYCERIDES), a sphingoid, a ceramide (CERAMIDES) (N-acylsphingoid) or a prenyl phosphate. (From IUPAC's webpage)
A gram-positive organism found in dairy products, fresh and salt water, marine organisms, insects, and decaying organic matter.
Sets of enzymatic reactions occurring in organisms and that form biochemicals by making new covalent bonds.
A family of gram-positive, aerobic actinomycetes found in soil and animal tissue. Some species are the cause of infection in man and animals.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Trehalose is a non-reducing disaccharide composed of two glucose molecules linked by an alpha, alpha-1,1-glycosidic bond, naturally found in some plants and microorganisms, serving as a cryoprotectant and providing cellular protection against various stress conditions.
Procedures for identifying types and strains of bacteria. The most frequently employed typing systems are BACTERIOPHAGE TYPING and SEROTYPING as well as bacteriocin typing and biotyping.
Enzymes that catalyze the joining of two molecules by the formation of a carbon-carbon bond. These are the carboxylating enzymes and are mostly biotinyl-proteins. EC 6.4.
Infections with bacteria of the genus CORYNEBACTERIUM.
A species of RHODOCOCCUS found in soil, herbivore dung, and in the intestinal tract of cows, horses, sheep, and pigs. It causes bronchopneumonia in foals and can be responsible for infection in humans compromised by immunosuppressive drug therapy, lymphoma, or AIDS.
Genes, found in both prokaryotes and eukaryotes, which are transcribed to produce the RNA which is incorporated into RIBOSOMES. Prokaryotic rRNA genes are usually found in OPERONS dispersed throughout the GENOME, whereas eukaryotic rRNA genes are clustered, multicistronic transcriptional units.
A species of gram-positive, aerobic bacteria that causes LEPROSY in man. Its organisms are generally arranged in clumps, rounded masses, or in groups of bacilli side by side.
The relative amounts of the PURINES and PYRIMIDINES in a nucleic acid.

A mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids accumulates meromycolates. (1/411)

Mycolic acids are a major constituent of the mycobacterial cell wall, and they form an effective permeability barrier to protect mycobacteria from antimicrobial agents. Although the chemical structures of mycolic acids are well established, little is known on their biosynthesis. We have isolated a mycolate-deficient mutant strain of Mycobacterium smegmatis mc2-155 by chemical mutagenesis followed by screening for increased sensitivity to novobiocin. This mutant also was hypersensitive to other hydrophobic compounds such as crystal violet, rifampicin, and erythromycin. Entry of hydrophobic probes into mutant cells occurred much more rapidly than that into the wild-type cells. HPLC and TLC analysis of fatty acid composition after saponification showed that the mutant failed to synthesize full-length mycolic acids. Instead, it accumulated a series of long-chain fatty acids, which were not detected in the wild-type strain. Analysis by 1H NMR, electrospray and electron impact mass spectroscopy, and permanganate cleavage of double bonds showed that these compounds corresponded to the incomplete meromycolate chain of mycolic acids, except for the presence of a beta-hydroxyl group. This direct identification of meromycolates as precursors of mycolic acids provides a strong support for the previously proposed pathway for mycolic acid biosynthesis involving the separate synthesis of meromycolate chain and the alpha-branch of mycolic acids, followed by the joining of these two branches.  (+info)

Synthesis of mycolic acids of mycobacteria: an assessment of the cell-free system in light of the whole genome. (2/411)

Mycolic acids are 70-90 carbon, alpha-alkyl, beta-hydroxy fatty acids constituting a major component of the cell envelope of Mycobacterium tuberculosis. The fact that the mycolic acid biosynthetic pathway is both essential in mycobacteria and the target for many first-line anti-TB drugs necessitates a detailed understanding of its biochemistry. A whole cell-free, but cell particulate- and membrane-containing enzyme preparation for mycolic acid biosynthesis was developed a few years ago and studied extensively. This system was shown to catalyze the synthesis of mature mycolic acids from [14C]acetate, but allows only minimal deposition into the cell wall proper. In the meantime the sequence of the entire genome of M. tuberculosis has been elucidated and its analysis using numerous protein sequence-based algorithms predicted cytoplasmic localization and a soluble, not a particulate, nature for the enzymes involved in the mycolic acid synthetic pathway. Accordingly, we re-assessed the 'cell-free' system for mycolic acid synthesis and concluded that it is probably due to the presence of unbroken cells, since viable cells were recovered from the cell wall preparation. The amount of whole cells depended upon the efficiency of the cell disruption method and conditions, and the amount of mycolic acid synthesized by the putative cell-free system correlated with the content of whole cells. Thus, accumulated results from the use of this 'cell-free' cell wall-based system should be re-evaluated in the light of these new data.  (+info)

Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis. (3/411)

Isoxyl (ISO), a thiourea (thiocarlide; 4, 4'-diisoamyloxythiocarbanilide), demonstrated potent activity against Mycobacterium tuberculosis H37Rv (MIC, 2.5 micrograms/ml), Mycobacterium bovis BCG (MIC, 0.5 microgram/ml), Mycobacterium avium (MIC, 2.0 microgram/ml), and Mycobacterium aurum A+ (MIC, 2.0 microgram/ml), resulting in complete inhibition of mycobacteria grown on solid media. Importantly, a panel of clinical isolates of M. tuberculosis from different geographical areas with various drug resistance patterns were all sensitive to ISO in the range of 1 to 10 microgram/ml. In a murine macrophage model, ISO exhibited bactericidal killing of viable intracellular M. tuberculosis in a dose-dependent manner (0.05 to 2.50 microgram/ml). The selective action of ISO on mycolic acid synthesis was studied through the use of [1, 2-14C]acetate labeling of M. tuberculosis H37Rv, M. bovis BCG, and M. aurum A+. At its MIC for M. tuberculosis, ISO inhibited the synthesis of both fatty acids and mycolic acids (alpha-mycolates by 91.6%, methoxymycolates by 94.3%, and ketomycolates by 91.1%); at its MIC in M. bovis BCG, ISO inhibited the synthesis of alpha-mycolates by 87.2% and that of ketomycolates by 88.5%; and the corresponding inhibitions for M. aurum A+ were 87.1% for alpha-mycolates, 87.2% for ketomycolates, and 86.5% for the wax-ester mycolates. A comparison with isoniazid (INH) and ethionamide (ETH) demonstrated marked similarity in action, i.e., inhibition of the synthesis of all kinds of mycolic acids. However, unlike INH and ETH, ISO also inhibited the synthesis of shorter-chain fatty acids. ISO showed no acute toxicity against primary macrophage cell cultures as demonstrated by diminution of redox activity. A homologous series of ISO derivatives were synthesized. Most derivatives were as effective or more effective than the parent compound in the agar proportion assay. Thus, these thioureas, like INH and ETH, specifically inhibit mycolic acid synthesis and show promise in counteracting a wide variety of drug-sensitive and -resistant strains of M. tuberculosis.  (+info)

Reduced glutaraldehyde susceptibility in Mycobacterium chelonae associated with altered cell wall polysaccharides. (4/411)

Glutaraldehyde-resistant Mycobacterium chelonae have been isolated from endoscope washer disinfectors and endoscope rinse water. The mechanism of glutaraldehyde resistance is not well understood. Two spontaneous, glutaraldehyde-resistant mutants of the sensitive type strain, NCTC 946, were investigated. The colony morphology of the two mutants differed from that of the the type strain: colonies of the former were dry and waxy whereas those of the latter were smooth and shiny. Increased resistance to glutaraldehyde of the mutants was matched by small increases in the MICs of rifampicin and ethambutol but not isoniazid. Both mutants showed increased surface hydrophobicity. No changes were identified in the extractable fatty acids or the mycolic acid components of the cell wall but a reduction in each of the resistant strains in the arabinogalactan/arabinomannan portion of the cell wall was detected.  (+info)

Gordonia polyisoprenivorans sp. nov., a rubber-degrading actinomycete isolated from an automobile tyre. (5/411)

A rubber-degrading bacterium (strain Kd2T) was isolated from fouling tyre water inside a deteriorated automobile tyre. The strain was aerobic, Grampositive, produced elementary branching hyphae which fragmented into rod/coccus-like elements and showed chemotaxonomic markers which were consistent with the classification of Gordonia, i.e. meso-diaminopimelic acid, N-glycolyl muramic acid, arabinose and galactose as diagnostic sugars, a fatty acid pattern composed of unbranched saturated and monounsaturated fatty acids with a considerable amount of tuberculostearic acid, and mycolic acids comprising 58-66 carbon atoms with two principal mycolic acids C60 and C62 counting for over 60%. Results of 16S rDNA analyses as well as chemotaxonomic results, led to the conclusion that Gordonia sp. strain Kd2T (= DSM 44302T) represents a new species within the genus Gordonia for which the name Gordonia polyisoprenivorans is proposed.  (+info)

Mycobacterium tusciae sp. nov. (6/411)

A new, slow-growing, scotochromogenic mycobacterium was isolated from a lymph node of an immunocompromised child and subsequently from tap water and from a respiratory specimen of a patient with chronic fibrosis. Alcohol-acid-fastness, lipid patterns and the G + C content clearly support the placement of this organism in the genus Mycobacterium. The isolates grew very slowly at temperatures ranging from 25 to 32 degrees C and showed activities of nitrate reductase, catalase, urease, arylsulfatase and Tween 80 hydrolysis. The organism was susceptible to all antimycobacterial drugs tested. The 16S rDNA sequence was unique and phylogenetic analysis placed the organism close to fast-growing species such as Mycobacterium farcinogenes, Mycobacterium komossense and Mycobacterium aichiense. These data support the conclusion that the isolates represent a new mycobacterial species, for which the name Mycobacterium tusciae sp. nov. is proposed. The type strain is strain FI-25796T; a culture of this strain has been deposited in the DSMZ as strain DSM 44338T.  (+info)

Sequence-based identification of Mycobacterium species using the MicroSeq 500 16S rDNA bacterial identification system. (7/411)

We evaluated the MicroSeq 500 16S rDNA Bacterial Sequencing Kit (PE Applied Biosystems), a 500-bp sequence-based identification system, for its ability to identify clinical Mycobacterium isolates. The organism identity was determined by comparing the 16S rDNA sequence to the MicroSeq database, which consists primarily of type strain sequences. A total of 113 isolates (18 different species), previously recovered and identified by routine methods from two clinical laboratories, were analyzed by the MicroSeq method. Isolates with discordant results were analyzed by hsp65 gene sequence analysis and in some cases repeat phenotypic identification, AccuProbe rRNA hybridization (Gen-Probe, Inc., San Diego, Calif.), or high-performance liquid chromatography of mycolic acids. For 93 (82%) isolates, the MicroSeq identity was concordant with the previously reported identity. For 18 (16%) isolates, the original identification was discordant with the MicroSeq identification. Of the 18 discrepant isolates, 7 (six unique sequences) were originally misidentified by phenotypic analysis or the AccuProbe assay but were correctly identified by the MicroSeq assay. Of the 18 discrepant isolates, 11 (seven unique sequences) were unusual species that were difficult to identify by phenotypic methods and, in all but one case, by molecular methods. The remaining two isolates (2%) failed definitive phenotypic identification, but the MicroSeq assay was able to definitively identify one of these isolates. The MicroSeq identification system is an accurate and rapid method for the identification of Mycobacterium spp.  (+info)

Quantitative use of fluorescent in situ hybridization to examine relationships between mycolic acid-containing actinomycetes and foaming in activated sludge plants. (8/411)

The formation of viscous foams on aeration basins and secondary clarifiers of activated sludge plants is a common and widespread problem. Foam formation is often attributed to the presence of mycolic acid-containing actinomycetes (mycolata). In order to examine the relationship between the number of mycolata and foam, we developed a group-specific probe targeting the 16S rRNA of the mycolata, a protocol to permeabilize mycolata, and a statistically robust quantification method. Statistical analyses showed that a lipase-based permeabilization method was quantitatively superior to previously described methods (P << 0.05). When mixed liquor and foam samples were examined, most of the mycolata present were rods or cocci, although filamentous mycolata were also observed. A nested analysis of variance showed that virtually all of the measured variance occurred between fields of view and not between samples. On this basis we determined that as few as five fields of view could be used to give a statistically meaningful sample. Quantitative fluorescent in situ hybridization (FISH) was used to examine the relationship between foaming and the concentration of mycolata in a 20-m(3) completely mixed activated sludge plant. Foaming occurred when the number of mycolata exceeded a certain threshold value. Baffling of the plant affected foaming without affecting the number of mycolata. We tentatively estimated that the threshold foaming concentration of mycolata was about 2 x 10(6) cells ml(-1) or 4 x 10(12) cells m(-2). We concluded that quantitative use of FISH is feasible and that quantification is a prerequisite for rational investigation of foaming in activated sludge.  (+info)

Mycolic acids are complex, long-chain fatty acids that are a major component of the cell wall in mycobacteria, including the bacteria responsible for tuberculosis and leprosy. These acids contribute to the impermeability and resistance to chemical agents of the mycobacterial cell wall, making these organisms difficult to eradicate. Mycolic acids are unique to mycobacteria and some related actinomycetes, and their analysis can be useful in the identification and classification of these bacteria.

"Mycobacterium" is a genus of gram-positive, aerobic, rod-shaped bacteria that are characterized by their complex cell walls containing large amounts of lipids. This genus includes several species that are significant in human and animal health, most notably Mycobacterium tuberculosis, which causes tuberculosis, and Mycobacterium leprae, which causes leprosy. Other species of Mycobacterium can cause various diseases in humans, including skin and soft tissue infections, lung infections, and disseminated disease in immunocompromised individuals. These bacteria are often resistant to common disinfectants and antibiotics, making them difficult to treat.

Actinomycetales is an order of Gram-positive bacteria that are characterized by their filamentous morphology and branching appearance, resembling fungi. These bacteria are often found in soil and water, and some species can cause diseases in humans and animals. The name "Actinomycetales" comes from the Greek words "actis," meaning ray or beam, and "mykes," meaning fungus.

The order Actinomycetales includes several families of medical importance, such as Mycobacteriaceae (which contains the tuberculosis-causing Mycobacterium tuberculosis), Corynebacteriaceae (which contains the diphtheria-causing Corynebacterium diphtheriae), and Actinomycetaceae (which contains the actinomycosis-causing Actinomyces israelii).

Actinomycetales are known for their complex cell walls, which contain a unique type of lipid called mycolic acid. This feature makes them resistant to many antibiotics and contributes to their ability to cause chronic infections. They can also form resistant structures called spores, which allow them to survive in harsh environments and contribute to their ability to cause disease.

Overall, Actinomycetales are important both as beneficial soil organisms and as potential pathogens that can cause serious diseases in humans and animals.

Cord factors are a group of glycolipids that are found on the surface of mycobacteria, including Mycobacterium tuberculosis, which is the bacterium that causes tuberculosis. These cord factors are called "cord factors" because they help to form characteristic "cords" or cable-like structures when mycobacteria grow in clumps.

Cord factors contribute to the virulence of mycobacteria by inhibiting the ability of certain immune cells, such as macrophages, to destroy the bacteria. They do this by preventing the fusion of lysosomes (which contain enzymes that can break down and kill the bacteria) with phagosomes (the compartments in which the bacteria are contained within the macrophage). This allows the mycobacteria to survive and replicate inside the host cells, leading to the development of tuberculosis.

Cord factors have also been shown to induce the production of pro-inflammatory cytokines, which can contribute to tissue damage and the pathogenesis of tuberculosis. Therefore, cord factors are an important target for the development of new therapies and vaccines against tuberculosis.

Corynebacterium is a genus of Gram-positive, rod-shaped bacteria that are commonly found on the skin and mucous membranes of humans and animals. Some species of Corynebacterium can cause disease in humans, including C. diphtheriae, which causes diphtheria, and C. jeikeium, which can cause various types of infections in immunocompromised individuals. Other species are part of the normal flora and are not typically pathogenic. The bacteria are characterized by their irregular, club-shaped appearance and their ability to form characteristic arrangements called palisades. They are facultative anaerobes, meaning they can grow in the presence or absence of oxygen.

'Mycobacterium tuberculosis' is a species of slow-growing, aerobic, gram-positive bacteria that demonstrates acid-fastness. It is the primary causative agent of tuberculosis (TB) in humans. This bacterium has a complex cell wall rich in lipids, including mycolic acids, which provides a hydrophobic barrier and makes it resistant to many conventional antibiotics. The ability of M. tuberculosis to survive within host macrophages and resist the immune response contributes to its pathogenicity and the difficulty in treating TB infections.

M. tuberculosis is typically transmitted through inhalation of infectious droplets containing the bacteria, which primarily targets the lungs but can spread to other parts of the body (extrapulmonary TB). The infection may result in a spectrum of clinical manifestations, ranging from latent TB infection (LTBI) to active disease. LTBI represents a dormant state where individuals are infected with M. tuberculosis but do not show symptoms and cannot transmit the bacteria. However, they remain at risk of developing active TB throughout their lifetime, especially if their immune system becomes compromised.

Effective prevention and control strategies for TB rely on early detection, treatment, and public health interventions to limit transmission. The current first-line treatments for drug-susceptible TB include a combination of isoniazid, rifampin, ethambutol, and pyrazinamide for at least six months. Multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of M. tuberculosis present significant challenges in TB control and require more complex treatment regimens.

Thioacetazone is an antituberculous drug that is primarily used in the treatment of tuberculosis. It works by inhibiting the synthesis of mycobacterial cell walls, thereby preventing the growth and multiplication of the bacteria that cause tuberculosis. Thioacetazone is often used in combination with other antituberculous drugs such as isoniazid and rifampicin to improve treatment outcomes and prevent drug resistance.

The chemical formula for thioacetazone is C4H6Cl2N2OS, and it is available in the form of tablets or capsules for oral administration. Common side effects of thioacetazone include skin rashes, gastrointestinal disturbances, and abnormal liver function tests. Rare but serious side effects may include severe skin reactions, hepatitis, and blood disorders. Thioacetazone is generally well-tolerated, but it should be used with caution in patients with liver or kidney disease, as well as those taking other medications that may interact with thioacetazone.

"Mycobacterium smegmatis" is a species of fast-growing, non-tuberculous mycobacteria (NTM). It is commonly found in the environment, including soil and water. This bacterium is known for its ability to form resistant colonies called biofilms. While it does not typically cause disease in humans, it can contaminate medical equipment and samples, potentially leading to misdiagnosis or infection. In rare cases, it has been associated with skin and soft tissue infections. It is often used in research as a model organism for studying mycobacterial biology and drug resistance due to its relatively harmless nature and rapid growth rate.

Thin-layer chromatography (TLC) is a type of chromatography used to separate, identify, and quantify the components of a mixture. In TLC, the sample is applied as a small spot onto a thin layer of adsorbent material, such as silica gel or alumina, which is coated on a flat, rigid support like a glass plate. The plate is then placed in a developing chamber containing a mobile phase, typically a mixture of solvents.

As the mobile phase moves up the plate by capillary action, it interacts with the stationary phase and the components of the sample. Different components of the mixture travel at different rates due to their varying interactions with the stationary and mobile phases, resulting in distinct spots on the plate. The distance each component travels can be measured and compared to known standards to identify and quantify the components of the mixture.

TLC is a simple, rapid, and cost-effective technique that is widely used in various fields, including forensics, pharmaceuticals, and research laboratories. It allows for the separation and analysis of complex mixtures with high resolution and sensitivity, making it an essential tool in many analytical applications.

Gordonia bacterium is a type of gram-positive, aerobic bacteria that belongs to the family Gordoniaceae. These bacteria are typically found in soil, water, and clinical specimens such as respiratory secretions, wounds, and blood. They are catalase-positive and oxidase-negative, and many species can produce colonies with a distinctive orange or pink color due to the production of pigments such as gordoniabactin.

Gordonia species are generally considered to be low-virulence organisms, but they have been associated with various types of infections, particularly in immunocompromised individuals. These infections can include respiratory tract infections, catheter-related bloodstream infections, and skin and soft tissue infections.

Gordonia species are often resistant to many antibiotics, including beta-lactams, macrolides, and aminoglycosides. Therefore, identification of the specific Gordonia species and susceptibility testing are important for guiding appropriate antimicrobial therapy.

Galactans are a type of complex carbohydrates known as oligosaccharides that are composed of galactose molecules. They can be found in certain plants, including beans, lentils, and some fruits and vegetables. In the human body, galactans are not digestible and can reach the colon intact, where they may serve as a substrate for fermentation by gut bacteria. This can lead to the production of short-chain fatty acids, which have been shown to have various health benefits. However, in some individuals with irritable bowel syndrome or other functional gastrointestinal disorders, consumption of galactans may cause digestive symptoms such as bloating, gas, and diarrhea.

Nocardia is a genus of aerobic, gram-positive, filamentous bacteria that can be found in soil, water, and decaying vegetation. It is known to cause various infectious diseases in humans and animals, known as nocardiosis. The infection often enters the body through inhalation, skin wounds, or surgical procedures. Nocardia species are opportunistic pathogens, meaning they mainly cause disease in individuals with weakened immune systems, such as those with HIV/AIDS, organ transplants, or cancer. The infection can affect various organs, including the lungs, brain, skin, and eyes, leading to symptoms like cough, fever, chest pain, weight loss, and skin abscesses. Proper diagnosis and treatment with antibiotics are crucial for managing nocardiosis.

Cyclopropanes are a class of organic compounds that contain a cyclic structure consisting of three carbon atoms joined by single bonds, forming a three-membered ring. The strain in the cyclopropane ring is due to the fact that the ideal tetrahedral angle at each carbon atom (109.5 degrees) cannot be achieved in a three-membered ring, leading to significant angular strain.

Cyclopropanes are important in organic chemistry because of their unique reactivity and synthetic utility. They can undergo various reactions, such as ring-opening reactions, that allow for the formation of new carbon-carbon bonds and the synthesis of complex molecules. Cyclopropanes have also been used as anesthetics, although their use in this application has declined due to safety concerns.

A cell wall is a rigid layer found surrounding the plasma membrane of plant cells, fungi, and many types of bacteria. It provides structural support and protection to the cell, maintains cell shape, and acts as a barrier against external factors such as chemicals and mechanical stress. The composition of the cell wall varies among different species; for example, in plants, it is primarily made up of cellulose, hemicellulose, and pectin, while in bacteria, it is composed of peptidoglycan.

Nontuberculous mycobacteria (NTM) are a group of environmental mycobacteria that do not cause tuberculosis or leprosy. They can be found in water, soil, and other natural environments. Some people may become infected with NTM, leading to various diseases depending on the site of infection, such as lung disease (most common), skin and soft tissue infections, lymphadenitis, and disseminated disease.

The clinical significance of NTM isolation is not always clear, as colonization without active infection can occur. Diagnosis typically requires a combination of clinical, radiological, microbiological, and sometimes molecular evidence to confirm the presence of active infection. Treatment usually involves multiple antibiotics for an extended period, depending on the species involved and the severity of disease.

Ethionamide is an antimicrobial medication used to treat tuberculosis (TB) caused by drug-resistant strains of the bacterium Mycobacterium tuberculosis. It belongs to a class of drugs called thioamides, which work by inhibiting the bacteria's ability to synthesize its cell wall.

Ethionamide is often used in combination with other TB medications to prevent the development of drug-resistant strains and improve treatment outcomes. Common side effects of ethionamide include gastrointestinal symptoms such as nausea, vomiting, and loss of appetite, as well as neurological symptoms such as dizziness, headache, and peripheral neuropathy.

It is important to note that the use of ethionamide should be under the close supervision of a healthcare professional, as it can cause serious side effects and its effectiveness may be affected by drug interactions or individual patient factors.

Fatty acid synthase type II (FASN2) is an alternative form of fatty acid synthase, which is a multi-functional enzyme complex responsible for the de novo synthesis of palmitate, a 16-carbon saturated fatty acid. In contrast to the classical type I fatty acid synthase (FASN), which is found in the cytoplasm and exists as a homodimer, FASN2 is localized in the mitochondria and consists of individual, monofunctional enzymes that catalyze each step of the fatty acid synthesis process.

The type II fatty acid synthase system includes several enzymes: acetyl-CoA carboxylase (ACC), which provides malonyl-CoA; 3-ketoacyl-CoA thiolase, which catalyzes the initial condensation of acetyl-CoA and malonyl-CoA to form acetoacetyl-CoA; 3-hydroxyacyl-CoA dehydrogenase/enoyl-CoA hydratase (HAD), which catalyzes the reduction, dehydration, and isomerization of acetoacetyl-CoA to form hydroxybutyryl-CoA; 3-ketoacyl-CoA reductase, which reduces hydroxybutyryl-CoA to butyryl-CoA; and enoyl-CoA reductase (ECR), which catalyzes the final reduction of butyryl-CoA to palmitate.

FASN2 is involved in various cellular processes, including energy metabolism, lipid biosynthesis, and protein acetylation. Dysregulation of FASN2 has been implicated in several diseases, such as cancer, obesity, and neurodegenerative disorders.

'Corynebacterium glutamicum' is a species of Gram-positive, rod-shaped bacteria that are commonly found in the environment, particularly in soil and water. It is a facultative anaerobe, which means it can grow with or without oxygen. The bacterium is non-pathogenic and has been widely studied and used in biotechnology due to its ability to produce various amino acids and other industrially relevant compounds.

The name 'Corynebacterium glutamicum' comes from its discovery as a bacterium that can ferment the amino acid glutamate, which is why it has been extensively used in the industrial production of L-glutamate, an important ingredient in many food products and feed additives.

In recent years, 'Corynebacterium glutamicum' has also gained attention as a potential platform organism for the production of various biofuels and biochemicals, including alcohols, organic acids, and hydrocarbons. Its genetic tractability and ability to utilize a wide range of carbon sources make it an attractive candidate for biotechnological applications.

"Mycobacterium phlei" is not a recognized medical condition or disease. Mycobacterium phlei is actually a species of non-tuberculous mycobacteria (NTM) that is commonly found in the environment, such as in soil and water. It is often used in laboratory settings as a reference strain for mycobacterial identification and research. This bacterium is not known to cause disease in humans and is generally considered to be non-pathogenic.

Phenylthiourea is not typically considered a medical term, but it is a chemical compound that is used in scientific research and has been studied in the context of medicine. Here's a definition from a chemistry perspective:

Phenylthiourea (PTU) is an organic compound with the formula C6H5NCS. It is a derivative of thiourea, where one hydrogen atom is replaced by a phenyl group. PTU is a white crystalline powder that is soluble in water and alcohol.

In medical terms, PTU has been used as a medication to treat hyperthyroidism (overactive thyroid gland) because it can inhibit the production of thyroid hormones. However, its use as a therapeutic agent has declined due to the availability of other medications with fewer side effects. It is still used in research settings to study various biological processes and diseases.

It's important to note that PTU should only be administered under the supervision of a healthcare professional, as it can have adverse effects if not used properly.

Chromatography, gas (GC) is a type of chromatographic technique used to separate, identify, and analyze volatile compounds or vapors. In this method, the sample mixture is vaporized and carried through a column packed with a stationary phase by an inert gas (carrier gas). The components of the mixture get separated based on their partitioning between the mobile and stationary phases due to differences in their adsorption/desorption rates or solubility.

The separated components elute at different times, depending on their interaction with the stationary phase, which can be detected and quantified by various detection systems like flame ionization detector (FID), thermal conductivity detector (TCD), electron capture detector (ECD), or mass spectrometer (MS). Gas chromatography is widely used in fields such as chemistry, biochemistry, environmental science, forensics, and food analysis.

Fatty acids are carboxylic acids with a long aliphatic chain, which are important components of lipids and are widely distributed in living organisms. They can be classified based on the length of their carbon chain, saturation level (presence or absence of double bonds), and other structural features.

The two main types of fatty acids are:

1. Saturated fatty acids: These have no double bonds in their carbon chain and are typically solid at room temperature. Examples include palmitic acid (C16:0) and stearic acid (C18:0).
2. Unsaturated fatty acids: These contain one or more double bonds in their carbon chain and can be further classified into monounsaturated (one double bond) and polyunsaturated (two or more double bonds) fatty acids. Examples of unsaturated fatty acids include oleic acid (C18:1, monounsaturated), linoleic acid (C18:2, polyunsaturated), and alpha-linolenic acid (C18:3, polyunsaturated).

Fatty acids play crucial roles in various biological processes, such as energy storage, membrane structure, and cell signaling. Some essential fatty acids cannot be synthesized by the human body and must be obtained through dietary sources.

"Nocardia asteroides" is a species of aerobic, gram-positive bacteria that can be found in soil and water. It is a type of actinomycete that can cause various infectious diseases in humans and animals, known as nocardiosis. The bacterium has the ability to form branching filaments, which can resemble fungal hyphae, and it often forms hard, rough colonies on culture media. Nocardia asteroides is known for its resistance to various antibiotics and can cause a range of clinical manifestations, including pulmonary, cutaneous, and disseminated infections. It is typically treated with drugs such as sulfonamides, trimethoprim-sulfamethoxazole, or imipenem.

Ribosomal RNA (rRNA) is a type of RNA that combines with proteins to form ribosomes, which are complex structures inside cells where protein synthesis occurs. The "16S" refers to the sedimentation coefficient of the rRNA molecule, which is a measure of its size and shape. In particular, 16S rRNA is a component of the smaller subunit of the prokaryotic ribosome (found in bacteria and archaea), and is often used as a molecular marker for identifying and classifying these organisms due to its relative stability and conservation among species. The sequence of 16S rRNA can be compared across different species to determine their evolutionary relationships and taxonomic positions.

Rhodococcus is a genus of gram-positive, aerobic, actinomycete bacteria that are widely distributed in the environment, including soil and water. Some species of Rhodococcus can cause opportunistic infections in humans and animals, particularly in individuals with weakened immune systems. These infections can affect various organs and tissues, such as the lungs, skin, and brain, and can range from mild to severe.

Rhodococcus species are known for their ability to degrade a wide variety of organic compounds, including hydrocarbons, making them important players in bioremediation processes. They also have complex cell walls that make them resistant to many antibiotics and disinfectants, which can complicate treatment of Rhodococcus infections.

Ribosomal DNA (rDNA) refers to the specific regions of DNA in a cell that contain the genes for ribosomal RNA (rRNA). Ribosomes are complex structures composed of proteins and rRNA, which play a crucial role in protein synthesis by translating messenger RNA (mRNA) into proteins.

In humans, there are four types of rRNA molecules: 18S, 5.8S, 28S, and 5S. These rRNAs are encoded by multiple copies of rDNA genes that are organized in clusters on specific chromosomes. In humans, the majority of rDNA genes are located on the short arms of acrocentric chromosomes 13, 14, 15, 21, and 22.

Each cluster of rDNA genes contains both transcribed and non-transcribed spacer regions. The transcribed regions contain the genes for the four types of rRNA, while the non-transcribed spacers contain regulatory elements that control the transcription of the rRNA genes.

The number of rDNA copies varies between species and even within individuals of the same species. The copy number can also change during development and in response to environmental factors. Variations in rDNA copy number have been associated with various diseases, including cancer and neurological disorders.

Isoniazid is an antimicrobial medication used for the prevention and treatment of tuberculosis (TB). It is a first-line medication, often used in combination with other TB drugs, to kill the Mycobacterium tuberculosis bacteria that cause TB. Isoniazid works by inhibiting the synthesis of mycolic acids, which are essential components of the bacterial cell wall. This leads to bacterial death and helps to control the spread of TB.

Isoniazid is available in various forms, including tablets, capsules, and liquid solutions. It can be taken orally or given by injection. The medication is generally well-tolerated, but it can cause side effects such as peripheral neuropathy, hepatitis, and skin rashes. Regular monitoring of liver function tests and supplementation with pyridoxine (vitamin B6) may be necessary to prevent or manage these side effects.

It is important to note that Isoniazid is not effective against drug-resistant strains of TB, and its use should be guided by the results of drug susceptibility testing. Additionally, it is essential to complete the full course of treatment as prescribed to ensure the successful eradication of the bacteria and prevent the development of drug-resistant strains.

Methyltransferases are a class of enzymes that catalyze the transfer of a methyl group (-CH3) from a donor molecule to an acceptor molecule, which is often a protein, DNA, or RNA. This transfer of a methyl group can modify the chemical and physical properties of the acceptor molecule, playing a crucial role in various cellular processes such as gene expression, signal transduction, and DNA repair.

In biochemistry, methyltransferases are classified based on the type of donor molecule they use for the transfer of the methyl group. The most common methyl donor is S-adenosylmethionine (SAM), a universal methyl group donor found in many organisms. Methyltransferases that utilize SAM as a cofactor are called SAM-dependent methyltransferases.

Abnormal regulation or function of methyltransferases has been implicated in several diseases, including cancer and neurological disorders. Therefore, understanding the structure, function, and regulation of these enzymes is essential for developing targeted therapies to treat these conditions.

Antitubercular agents, also known as anti-tuberculosis drugs or simply TB drugs, are a category of medications specifically used for the treatment and prevention of tuberculosis (TB), a bacterial infection caused by Mycobacterium tuberculosis. These drugs target various stages of the bacteria's growth and replication process to eradicate it from the body or prevent its spread.

There are several first-line antitubercular agents, including:

1. Isoniazid (INH): This is a bactericidal drug that inhibits the synthesis of mycolic acids, essential components of the mycobacterial cell wall. It is primarily active against actively growing bacilli.
2. Rifampin (RIF) or Rifampicin: A bactericidal drug that inhibits DNA-dependent RNA polymerase, preventing the transcription of genetic information into mRNA. This results in the interruption of protein synthesis and ultimately leads to the death of the bacteria.
3. Ethambutol (EMB): A bacteriostatic drug that inhibits the arabinosyl transferase enzyme, which is responsible for the synthesis of arabinan, a crucial component of the mycobacterial cell wall. It is primarily active against actively growing bacilli.
4. Pyrazinamide (PZA): A bactericidal drug that inhibits the synthesis of fatty acids and mycolic acids in the mycobacterial cell wall, particularly under acidic conditions. PZA is most effective during the initial phase of treatment when the bacteria are in a dormant or slow-growing state.

These first-line antitubercular agents are often used together in a combination therapy to ensure complete eradication of the bacteria and prevent the development of drug-resistant strains. Treatment duration typically lasts for at least six months, with the initial phase consisting of daily doses of INH, RIF, EMB, and PZA for two months, followed by a continuation phase of INH and RIF for four months.

Second-line antitubercular agents are used when patients have drug-resistant TB or cannot tolerate first-line drugs. These include drugs like aminoglycosides (e.g., streptomycin, amikacin), fluoroquinolones (e.g., ofloxacin, moxifloxacin), and injectable bacteriostatic agents (e.g., capreomycin, ethionamide).

It is essential to closely monitor patients undergoing antitubercular therapy for potential side effects and ensure adherence to the treatment regimen to achieve optimal outcomes and prevent the development of drug-resistant strains.

"Mycobacterium bovis" is a species of slow-growing, aerobic, gram-positive bacteria in the family Mycobacteriaceae. It is the causative agent of tuberculosis in cattle and other animals, and can also cause tuberculosis in humans, particularly in those who come into contact with infected animals or consume unpasteurized dairy products from infected cows. The bacteria are resistant to many common disinfectants and survive for long periods in a dormant state, making them difficult to eradicate from the environment. "Mycobacterium bovis" is closely related to "Mycobacterium tuberculosis," the bacterium that causes tuberculosis in humans, and both species share many genetic and biochemical characteristics.

Mycobacterium infections are a group of infectious diseases caused by various species of the Mycobacterium genus, including but not limited to M. tuberculosis (which causes tuberculosis), M. avium complex (which causes pulmonary and disseminated disease, particularly in immunocompromised individuals), M. leprae (which causes leprosy), and M. ulcerans (which causes Buruli ulcer). These bacteria are known for their ability to resist destruction by normal immune responses and many disinfectants due to the presence of a waxy mycolic acid layer in their cell walls.

Infection typically occurs through inhalation, ingestion, or direct contact with contaminated materials. The severity and manifestations of the disease can vary widely depending on the specific Mycobacterium species involved, the route of infection, and the host's immune status. Symptoms may include cough, fever, night sweats, weight loss, fatigue, skin lesions, or lymphadenitis. Diagnosis often requires specialized laboratory tests, such as culture or PCR-based methods, to identify the specific Mycobacterium species involved. Treatment typically involves a combination of antibiotics and may require long-term therapy.

Gas Chromatography-Mass Spectrometry (GC-MS) is a powerful analytical technique that combines the separating power of gas chromatography with the identification capabilities of mass spectrometry. This method is used to separate, identify, and quantify different components in complex mixtures.

In GC-MS, the mixture is first vaporized and carried through a long, narrow column by an inert gas (carrier gas). The various components in the mixture interact differently with the stationary phase inside the column, leading to their separation based on their partition coefficients between the mobile and stationary phases. As each component elutes from the column, it is then introduced into the mass spectrometer for analysis.

The mass spectrometer ionizes the sample, breaks it down into smaller fragments, and measures the mass-to-charge ratio of these fragments. This information is used to generate a mass spectrum, which serves as a unique "fingerprint" for each compound. By comparing the generated mass spectra with reference libraries or known standards, analysts can identify and quantify the components present in the original mixture.

GC-MS has wide applications in various fields such as forensics, environmental analysis, drug testing, and research laboratories due to its high sensitivity, specificity, and ability to analyze volatile and semi-volatile compounds.

Bacterial DNA refers to the genetic material found in bacteria. It is composed of a double-stranded helix containing four nucleotide bases - adenine (A), thymine (T), guanine (G), and cytosine (C) - that are linked together by phosphodiester bonds. The sequence of these bases in the DNA molecule carries the genetic information necessary for the growth, development, and reproduction of bacteria.

Bacterial DNA is circular in most bacterial species, although some have linear chromosomes. In addition to the main chromosome, many bacteria also contain small circular pieces of DNA called plasmids that can carry additional genes and provide resistance to antibiotics or other environmental stressors.

Unlike eukaryotic cells, which have their DNA enclosed within a nucleus, bacterial DNA is present in the cytoplasm of the cell, where it is in direct contact with the cell's metabolic machinery. This allows for rapid gene expression and regulation in response to changing environmental conditions.

Phylogeny is the evolutionary history and relationship among biological entities, such as species or genes, based on their shared characteristics. In other words, it refers to the branching pattern of evolution that shows how various organisms have descended from a common ancestor over time. Phylogenetic analysis involves constructing a tree-like diagram called a phylogenetic tree, which depicts the inferred evolutionary relationships among organisms or genes based on molecular sequence data or other types of characters. This information is crucial for understanding the diversity and distribution of life on Earth, as well as for studying the emergence and spread of diseases.

Esters are organic compounds that are formed by the reaction between an alcohol and a carboxylic acid. They are widely found in nature and are used in various industries, including the production of perfumes, flavors, and pharmaceuticals. In the context of medical definitions, esters may be mentioned in relation to their use as excipients in medications or in discussions of organic chemistry and biochemistry. Esters can also be found in various natural substances such as fats and oils, which are triesters of glycerol and fatty acids.

Diaminopimelic acid (DAP) is a biochemical compound that is an important intermediate in the biosynthesis of several amino acids and the cell wall of bacteria. It is a derivative of the amino acid lysine, and is a key component of the peptidoglycan layer of bacterial cell walls. Diaminopimelic acid is not commonly found in proteins of higher organisms, making it a useful marker for the identification and study of bacterial cell wall components and biosynthetic pathways.

Bacterial proteins are a type of protein that are produced by bacteria as part of their structural or functional components. These proteins can be involved in various cellular processes, such as metabolism, DNA replication, transcription, and translation. They can also play a role in bacterial pathogenesis, helping the bacteria to evade the host's immune system, acquire nutrients, and multiply within the host.

Bacterial proteins can be classified into different categories based on their function, such as:

1. Enzymes: Proteins that catalyze chemical reactions in the bacterial cell.
2. Structural proteins: Proteins that provide structural support and maintain the shape of the bacterial cell.
3. Signaling proteins: Proteins that help bacteria to communicate with each other and coordinate their behavior.
4. Transport proteins: Proteins that facilitate the movement of molecules across the bacterial cell membrane.
5. Toxins: Proteins that are produced by pathogenic bacteria to damage host cells and promote infection.
6. Surface proteins: Proteins that are located on the surface of the bacterial cell and interact with the environment or host cells.

Understanding the structure and function of bacterial proteins is important for developing new antibiotics, vaccines, and other therapeutic strategies to combat bacterial infections.

Mass spectrometry (MS) is an analytical technique used to identify and quantify the chemical components of a mixture or compound. It works by ionizing the sample, generating charged molecules or fragments, and then measuring their mass-to-charge ratio in a vacuum. The resulting mass spectrum provides information about the molecular weight and structure of the analytes, allowing for identification and characterization.

In simpler terms, mass spectrometry is a method used to determine what chemicals are present in a sample and in what quantities, by converting the chemicals into ions, measuring their masses, and generating a spectrum that shows the relative abundances of each ion type.

Glycolipids are a type of lipid (fat) molecule that contain one or more sugar molecules attached to them. They are important components of cell membranes, where they play a role in cell recognition and signaling. Glycolipids are also found on the surface of some viruses and bacteria, where they can be recognized by the immune system as foreign invaders.

There are several different types of glycolipids, including cerebrosides, gangliosides, and globosides. These molecules differ in the number and type of sugar molecules they contain, as well as the structure of their lipid tails. Glycolipids are synthesized in the endoplasmic reticulum and Golgi apparatus of cells, and they are transported to the cell membrane through vesicles.

Abnormalities in glycolipid metabolism or structure have been implicated in a number of diseases, including certain types of cancer, neurological disorders, and autoimmune diseases. For example, mutations in genes involved in the synthesis of glycolipids can lead to conditions such as Tay-Sachs disease and Gaucher's disease, which are characterized by the accumulation of abnormal glycolipids in cells.

Brevibacterium is a genus of Gram-positive, rod-shaped bacteria that are commonly found in nature, particularly in soil, water, and various types of decaying organic matter. Some species of Brevibacterium can also be found on the skin of animals and humans, where they play a role in the production of body odor.

Brevibacterium species are known for their ability to produce a variety of enzymes that allow them to break down complex organic compounds into simpler molecules. This makes them useful in a number of industrial applications, such as the production of cheese and other fermented foods, as well as in the bioremediation of contaminated environments.

In medical contexts, Brevibacterium species are rarely associated with human disease. However, there have been occasional reports of infections caused by these bacteria, particularly in individuals with weakened immune systems or who have undergone surgical procedures. These infections can include bacteremia (bloodstream infections), endocarditis (inflammation of the heart valves), and soft tissue infections. Treatment typically involves the use of antibiotics that are effective against Gram-positive bacteria, such as vancomycin or teicoplanin.

Biosynthetic pathways refer to the series of biochemical reactions that occur within cells and living organisms, leading to the production (synthesis) of complex molecules from simpler precursors. These pathways involve a sequence of enzyme-catalyzed reactions, where each reaction builds upon the product of the previous one, ultimately resulting in the formation of a specific biomolecule.

Examples of biosynthetic pathways include:

1. The Krebs cycle (citric acid cycle) - an essential metabolic pathway that generates energy through the oxidation of acetyl-CoA derived from carbohydrates, fats, and proteins.
2. Glycolysis - a process that breaks down glucose into pyruvate to generate ATP and NADH.
3. Gluconeogenesis - the synthesis of glucose from non-carbohydrate precursors such as lactate, pyruvate, glycerol, and certain amino acids.
4. Fatty acid synthesis - a process that produces fatty acids from acetyl-CoA and malonyl-CoA through a series of reduction reactions.
5. Amino acid synthesis - the production of various amino acids from simpler precursors, often involving intermediates in central metabolic pathways like the Krebs cycle or glycolysis.
6. Steroid biosynthesis - the formation of steroids from simple precursors such as cholesterol and its derivatives.
7. Terpenoid biosynthesis - the production of terpenes, terpenoids, and sterols from isoprene units (isopentenyl pyrophosphate).
8. Nucleotide synthesis - the generation of nucleotides, the building blocks of DNA and RNA, through complex biochemical pathways involving various precursors and cofactors.

Understanding biosynthetic pathways is crucial for comprehending cellular metabolism, developing drugs that target specific metabolic processes, and engineering organisms with desired traits in synthetic biology and metabolic engineering applications.

Nocardiaceae is a family of aerobic, gram-positive bacteria with branching filaments that are often found in soil and water. These organisms are known for their ability to form tough, persister colonies called "actinomycetoma" in human and animal tissue. They are opportunistic pathogens, meaning they primarily cause infection in individuals with weakened immune systems. Nocardiaceae includes several genera, the most notable being Nocardia, which is responsible for a variety of diseases in humans, including pulmonary, cutaneous, and central nervous system infections.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Trehalose is a type of disaccharide, which is a sugar made up of two monosaccharides. It consists of two glucose molecules joined together in a way that makes it more stable and resistant to breakdown by enzymes and heat. This property allows trehalose to be used as a protectant for biological materials during freeze-drying and storage, as well as a food additive as a sweetener and preservative.

Trehalose is found naturally in some plants, fungi, insects, and microorganisms, where it serves as a source of energy and protection against environmental stresses such as drought, heat, and cold. In recent years, there has been interest in the potential therapeutic uses of trehalose for various medical conditions, including neurodegenerative diseases, diabetes, and cancer.

Medically speaking, trehalose may be used in some pharmaceutical formulations as an excipient or stabilizer, and it is also being investigated as a potential therapeutic agent for various diseases. However, its use as a medical treatment is still not widely established, and further research is needed to determine its safety and efficacy.

Bacterial typing techniques are methods used to identify and differentiate bacterial strains or isolates based on their unique characteristics. These techniques are essential in epidemiological studies, infection control, and research to understand the transmission dynamics, virulence, and antibiotic resistance patterns of bacterial pathogens.

There are various bacterial typing techniques available, including:

1. **Bacteriophage Typing:** This method involves using bacteriophages (viruses that infect bacteria) to identify specific bacterial strains based on their susceptibility or resistance to particular phages.
2. **Serotyping:** It is a technique that differentiates bacterial strains based on the antigenic properties of their cell surface components, such as capsules, flagella, and somatic (O) and flagellar (H) antigens.
3. **Biochemical Testing:** This method uses biochemical reactions to identify specific metabolic pathways or enzymes present in bacterial strains, which can be used for differentiation. Commonly used tests include the catalase test, oxidase test, and various sugar fermentation tests.
4. **Molecular Typing Techniques:** These methods use genetic markers to identify and differentiate bacterial strains at the DNA level. Examples of molecular typing techniques include:
* **Pulsed-Field Gel Electrophoresis (PFGE):** This method uses restriction enzymes to digest bacterial DNA, followed by electrophoresis in an agarose gel under pulsed electrical fields. The resulting banding patterns are analyzed and compared to identify related strains.
* **Multilocus Sequence Typing (MLST):** It involves sequencing specific housekeeping genes to generate unique sequence types that can be used for strain identification and phylogenetic analysis.
* **Whole Genome Sequencing (WGS):** This method sequences the entire genome of a bacterial strain, providing the most detailed information on genetic variation and relatedness between strains. WGS data can be analyzed using various bioinformatics tools to identify single nucleotide polymorphisms (SNPs), gene deletions or insertions, and other genetic changes that can be used for strain differentiation.

These molecular typing techniques provide higher resolution than traditional methods, allowing for more accurate identification and comparison of bacterial strains. They are particularly useful in epidemiological investigations to track the spread of pathogens and identify outbreaks.

Carbon-carbon ligases are a type of enzyme that catalyze the formation of carbon-carbon bonds between two molecules. These enzymes play important roles in various biological processes, including the biosynthesis of natural products and the metabolism of carbohydrates and lipids.

Carbon-carbon ligases can be classified into several categories based on the type of reaction they catalyze. For example, aldolases catalyze the condensation of an aldehyde or ketone with another molecule to form a new carbon-carbon bond and a new carbonyl group. Other examples include the polyketide synthases (PKSs) and nonribosomal peptide synthetases (NRPSs), which are large multienzyme complexes that catalyze the sequential addition of activated carbon units to form complex natural products.

Carbon-carbon ligases are important targets for drug discovery and development, as they play critical roles in the biosynthesis of many disease-relevant molecules. Inhibitors of these enzymes have shown promise as potential therapeutic agents for a variety of diseases, including cancer, infectious diseases, and metabolic disorders.

Corynebacterium infections are caused by bacteria belonging to the genus Corynebacterium, which are gram-positive, rod-shaped organisms that commonly inhabit the skin and mucous membranes of humans and animals. While many species of Corynebacterium are harmless commensals, some can cause a range of infections, particularly in individuals with compromised immune systems or underlying medical conditions.

The most common Corynebacterium species that causes infection is C. diphtheriae, which is responsible for diphtheria, a potentially life-threatening respiratory illness characterized by the formation of a thick, grayish membrane in the throat and upper airways. Other Corynebacterium species, such as C. jeikeium, C. urealyticum, and C. striatum, can cause various types of healthcare-associated infections, including bacteremia, endocarditis, pneumonia, and skin and soft tissue infections.

Corynebacterium infections are typically treated with antibiotics, such as penicillin, erythromycin, or vancomycin, depending on the species of bacteria involved and the patient's medical history. In some cases, surgical intervention may be necessary to drain abscesses or remove infected tissue. Preventive measures, such as vaccination against C. diphtheriae and good hygiene practices, can help reduce the risk of Corynebacterium infections.

Rhodococcus equi is a gram-positive, aerobic, facultatively intracellular bacterium that is commonly found in the environment, particularly in soil and dust contaminated with animal feces. It is a significant pathogen in horses, causing pneumonia and other respiratory tract infections, especially in foals. However, it can also cause various infectious diseases in other animals, including humans, particularly in individuals who are immunocompromised or have underlying lung disease.

In humans, R. equi infection often manifests as pulmonary disease, characterized by cough, fever, and chest pain, although disseminated disease can occur in immunocompromised patients. The diagnosis of R. equi infection typically involves the isolation and identification of the organism from clinical specimens such as sputum or tissue samples, followed by antimicrobial susceptibility testing to guide therapy. Treatment usually involves a combination of antibiotics, including macrolides, rifamycins, and aminoglycosides, for an extended period.

rRNA (ribosomal RNA) is not a type of gene itself, but rather a crucial component that is transcribed from genes known as ribosomal DNA (rDNA). In cells, rRNA plays an essential role in protein synthesis by assembling with ribosomal proteins to form ribosomes. Ribosomes are complex structures where the translation of mRNA into proteins occurs. There are multiple types of rRNA molecules, including 5S, 5.8S, 18S, and 28S rRNAs in eukaryotic cells, each with specific functions during protein synthesis.

In summary, 'Genes, rRNA' would refer to the genetic regions (genes) that code for ribosomal RNA molecules, which are vital components of the protein synthesis machinery within cells.

"Mycobacterium leprae" is a slow-growing, rod-shaped, gram-positive bacterium that is the causative agent of leprosy, a chronic infectious disease that primarily affects the skin, peripheral nerves, and mucosal surfaces of the upper respiratory tract. The bacterium was discovered in 1873 by Gerhard Armauer Hansen, a Norwegian physician, and is named after him as "Hansen's bacillus."

"Mycobacterium leprae" has a unique cell wall that contains high amounts of lipids, which makes it resistant to many common disinfectants and antibiotics. It can survive and multiply within host macrophages, allowing it to evade the immune system and establish a chronic infection.

Leprosy is a treatable disease with multidrug therapy (MDT), which combines several antibiotics such as dapsone, rifampicin, and clofazimine. Early diagnosis and treatment can prevent the progression of the disease and reduce its transmission to others.

Base composition in genetics refers to the relative proportion of the four nucleotide bases (adenine, thymine, guanine, and cytosine) in a DNA or RNA molecule. In DNA, adenine pairs with thymine, and guanine pairs with cytosine, so the base composition is often expressed in terms of the ratio of adenine + thymine (A-T) to guanine + cytosine (G-C). This ratio can vary between species and even between different regions of the same genome. The base composition can provide important clues about the function, evolution, and structure of genetic material.

The remaining 10% to 15% of the mycolic acids are keto-mycolic acids, which contain several ketone groups. Mycolic acids impart ... Most mycolic acids also contain various functional groups. M. tuberculosis produces three main types of mycolic acids: alpha-, ... Methoxy-mycolic acids, which contain several methoxy groups, constitute between 10% and 15% of the mycolic acids in the ... Mycolic acids were first isolated by Stodola et al. in 1938 from an extract of M. tuberculosis. Mycolic acids are composed of a ...
They are non-acid fast and non-spore-forming facultative anaerobes. Their cell walls contain mycolic acids. G+C content ... C. uropygiale has adapted its metabolism to its habitat, as it lost the ability to produce these fatty acids by itself. In ... C. uropygiale grows on complex media supplemented with monounsaturated fatty acids (e. g. lysogeny broth (LB) agar supplemented ... It uses the fatty acids of its surroundings rather than synthesizing them by itself. ...
Cultivated with Mycolic Acid Containing Bacterium". Organic Letters. 17 (6): 1501-1504. doi:10.1021/acs.orglett.5b00385. ISSN ... "Mycolic Acid Containing Bacterium Stimulates Tandem Cyclization of Polyene Macrolactam in a Lake Sediment Derived Rare ... Multicyclic Macrolactams Isolated from Combined Culture of Streptomyces with Mycolic Acid-Containing Bacterium". Journal of ...
Mycobacteria have cell walls with peptidoglycan, arabinogalactan, and mycolic acid; a waxy outer mycomembrane of mycolic acid; ... Since this genus has cell walls with a waxy lipid-rich outer layer that contains high concentrations of mycolic acid, acid-fast ... The distinguishing characteristic of all Mycobacterium species is a thick, hydrophobic, and mycolic acid-rich cell wall made of ... instead requiring a multi-drug antibiotic treatment of isoniazid to inhibit mycolic acid synthesis, rifampicin to interfere ...
... mtFabH and is a crucial link between the fatty acid synthase-I and fatty acid synthase-II pathways producing mycolic acids. FAS ... whereas the C26 fatty acid constitutes the alpha branch of the final mycolic acid. MtFabH has been proposed to be the link ... their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development". Mol. Microbiol. 64 (6): ... Schroeder EK, de Souza N, Santos DS, Blanchard JS, Basso LA (September 2002). "Drugs that inhibit mycolic acid biosynthesis in ...
It is a non-motile, acid fast bacterium. The cell walls are composed primarily of Mycolic acids. The cells are irregular rods, ... Mycobacterium orygis uses the host's cells internal fatty acids for both a carbon source and an energy source. These molecules ...
However, the mycolic acid in the cell wall of M. tuberculosis does not absorb the stain. Instead, acid-fast stains such as ... Saturated with long-chain fatty acids or mycolic acids, the mycobacterial cell presents a robust, relatively insoluble barrier ... Its unusual cell wall is rich in lipids such as mycolic acid and cord factor glycolipid, is likely responsible for its ... Xu Z, Meshcheryakov VA, Poce G, Chng SS (July 2017). "MmpL3 is the flippase for mycolic acids in mycobacteria". Proceedings of ...
The mechanism of action is thought to be through disruption of mycolic acid. Expression of the ethA gene is controlled by ethR ... It is believed to work by interfering with the use of mycolic acid. Ethionamide was discovered in 1956 and approved for medical ... Quémard A, Lanéelle G, Lacave C (June 1992). "Mycolic acid synthesis: a target for ethionamide in mycobacteria?". Antimicrobial ... the encouraging case of inhibitors of mycolic acid biosynthesis". Expert Review of Anti-Infective Therapy. 11 (4): 429-440. doi ...
... as well as corynemycolic acid (a mycolic acid with 22 to 26 carbon atoms), bound by disaccharide bonds called L-Rhap-(1 → 4)--D ... Keddie, R. M.; Cure, G. L. (1977). "The Cell Wall Composition and Distribution of Free Mycolic Acids in Named Strains of ... nov., a novel corynebacterium that does not contain mycolic acids". International Journal of Systematic Bacteriology. 48 (4): ... Cooper, D. G.; Zajic, J. E.; Gracey, D. E. (1979). "Analysis of corynomycolic acids and other fatty acids produced by ...
"Novel mycolic acid-containing bacteria in the family Segniliparaceae fam. nov., including the genus Segniliparus gen. nov., ...
Huang CC, Smith CV, Glickman MS, Jacobs WR, Sacchettini JC (March 2002). "Crystal structures of mycolic acid cyclopropane ...
The hydrophobicity of mycolic acids is a barrier to drug entry. Additionally, the mycolyl arabinogalactan peptidoglycan is ... The arabinan portion of the polymer is a complex branched structure, usually capped with mycolic acids; the arabinan glycosidic ... The non-reducing end of arabinogalactan is covalently attached to the mycolic acids of the outer membrane. ... of the pentaarabinosyl units are substituted by mycolic acids, leaving the minority (33%) available for interaction with the ...
used FBA to study the mycolic acid pathway in Mycobacterium tuberculosis. Mycolic acids are known to be important to M. ... Raman, Karthik; Rajagopalan, Preethi; Chandra, Nagasuma (2005). "Flux Balance Analysis of Mycolic Acid Pathway: Targets for ... Nucleic Acids Research. 44 (D1): D515-D522. doi:10.1093/nar/gkv1049. ISSN 0305-1048. PMC 4702785. PMID 26476456. Schellenberger ...
Sathyamoorthy N, Takayama K (1987). "Purification and characterization of a novel mycolic acid exchange enzyme from ...
... translates to mycolic acid) and the Latin noun bacter (translates to rod). Together the name refers to a genus of mycolic acid ... comparative genomic analyses and average amino acid identity values. In addition to this genus, the study proposed the division ...
Mycolic acids of the mycobacteria keep this stain when decolorising with the acid alcohol. The method is more rapid and ... Smears are prepared just like that for ZN staining Stain with Auramine-Phenol for 20 mins Rinse with water Decolourise in acid ... "Comparison of the value of two different sputum staining for diagnosis of acid-fast bacilli". Retrieved 19 November 2012. " ...
The cellular membrane of N. sinuspersici is also unique, most notably lacking mycolic acids. Strains of N. sinuspersici can ... and fatty acids. The bacterium also produces a serine protease capable of rapidly breaking down milk protein. N. sinuspersici ...
The mycomembrane is unique and composed of very-long chain fatty acids, mycolic acids. These proteins are structurally ...
The name Mycolicibacterium is derived from the Latin noun acidum mycolicum (translates to mycolic acid) and the Latin noun ... Together the name refers to a genus of mycolic acid containing rod-shaped bacteria. Mycolicibacterium is a genus of rapidly- ... comparative genomic analyses and average amino acid identity values. In addition to this genus, the study proposed the division ...
"Diversion of phagosome trafficking by pathogenic Rhodococcus equi depends on mycolic acid chain length". Cellular Microbiology ...
May 1999). "Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis". ... inhibiting synthesis of oleic acid and tuberculostearic acid. Thiocarlide has considerable antimycobacterial activity in vitro ... Unlike these two drugs, however, isoxyl also partially inhibits the synthesis of fatty acids.[citation needed] Thiocarlide was ...
The name Mycolicibacillus is derived from the Latin noun acidum mycolicum (translates to mycolic acid) and the Latin noun ... Together the name refers to a genus of mycolic acid-containing, rod-shaped bacteria. While majority of the genus are slow ... comparative genomic analyses and average amino acid identity values. In addition to this genus, the study proposed the division ...
... works by blocking the manufacture of mycolic acids thus destabilising the bacterial cell wall. It is in the ...
"A Novel Mycolic Acid Cyclopropane Synthetase Is Required for Cording, Persistence, and Virulence of Mycobacterium tuberculosis ... Mycobacterium smegmatis is an acid-fast bacterial species in the phylum Actinomycetota and the genus Mycobacterium. It is 3.0 ... Gordon RE, Smith MM (July 1953). "Rapidly growing, acid fast bacteria. I. Species' descriptions of Mycobacterium phlei Lehmann ...
Groups inoculated with mycolic acid or C. pseudotuberculosis were evaluated through histopathology compared to a control. Both ... Mycolic acid provides a protective barrier, allowing the bacterial cell to resist lysosomal degradation by eukaryotic, ... Another mechanism of lymphatic transport is facilitated by the presence of a mycolic acid surface lipid. This coats the C. ... The importance of this virulence factor has also been highlighted where mice that have been injected with mycolic acid were ...
"Trafficking pathways of mycolic acids: structures, origin, mechanism of formation, and storage form of mycobacteric acids" (PDF ... Heptatriacontanoic acid, or heptatriacontylic acid, is a 37-carbon saturated fatty acid. Heptatriacontanoic acid is present in ... List of saturated fatty acids List of carboxylic acids Lai, X. Y.; Zhao, Y. Y.; Liang, H. (2006). "Studies on chemical ... The expired U.S. patent 5502226 covers a method of ω-hydroxy acid preparation that includes heptatriacontanoic acid. ...
This process inhibits the synthesis of mycolic acids, which are required components of the mycobacterial cell wall. A range of ... Evidence suggests that isoniazid prevents mycolic acid synthesis in M. avium complex as in M. tuberculosis and although this is ... In another method, isoniazid was claimed to have been made from citric acid starting material. It can in theory be made from ... Isonicotinic acid hydrazide is also used in chromatography to differentiate between various degrees of conjugation in organic ...
The mycobacterial wall is composed of lipids and polysaccharides and also contains high amounts of mycolic acid. Purified cell ... Nucleic acid variants normally associated with viruses, such as double-stranded RNA (dsRNA), recognized by TLR3 or unmethylated ... Lipoteichoic acid (LTA) from gram-positive bacteria, bacterial lipoproteins (sBLP), a phenol soluble factor from Staphylococcus ... Dammermann W, Wollenberg L, Bentzien F, Lohse A, Lüth S (October 2013). "Toll like receptor 2 agonists lipoteichoic acid and ...
However, M. tuberculosis has a thick, waxy mycolic acid capsule that protects it from these toxic substances. M. tuberculosis ... The most common acid-fast staining techniques are the Ziehl-Neelsen stain and the Kinyoun stain, which dye acid-fast bacilli a ... or does not retain dye as a result of the high lipid and mycolic acid content of its cell wall. MTB can withstand weak ... Nucleic acid amplification tests and adenosine deaminase testing may allow rapid diagnosis of TB. Blood tests to detect ...
"Recognition of anti-mycolic acid antibody at self-assembled mycolic acid antigens on a gold electrode: a potential impedimetric ... Recognition of anti-mycolic acid antigens on gold electrode: A potential impedimetric immunosensing platform for active ...
The remaining 10% to 15% of the mycolic acids are keto-mycolic acids, which contain several ketone groups. Mycolic acids impart ... Most mycolic acids also contain various functional groups. M. tuberculosis produces three main types of mycolic acids: alpha-, ... Methoxy-mycolic acids, which contain several methoxy groups, constitute between 10% and 15% of the mycolic acids in the ... Mycolic acids were first isolated by Stodola et al. in 1938 from an extract of M. tuberculosis. Mycolic acids are composed of a ...
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint ...
The analysis of mycolic acid (MA) using LC-MS indicated deficiency of alpha-MA and epoxy-MA in aceE-mut strain whereas ... Over all, this study indicates that aceE gene plays a significant role in the mycolic acid synthesis and affects the colony ... The lipids composition other than mycolic acid of WT, aceE-mut and Comp strain; b. The mycolic acid composition of WT, aceE-mut ... Disruption of aceE gene affected the mycolic acid composition. The mycolic acid (C60 ~ C90) composition was analyzed by HPLC ...
... Details. Last Updated: Wednesday, 03 April 2019 16:15 Groenewald, Wilma; Bulacu, Monica; Croft, Anna; Marrink, ... persistence is attributed partly to the presence of lipids, such as mycolic acids. (MAs), which make the cell wall impermeable ...
Mycolic acids are a class of long chain α-alkyl-β-hydroxy fatty acids which constitute a significant part of the outer membrane ... Methoxy mycolic acid (azide) - Any other pack size. Enquire now Methoxy mycolic acid (azide) - 500 ug. € 295,00. Methoxy ... Cis keto methoxy mycolic acid (natural cis cyclopropyl) - 500 ug. € 295,00. Cis keto methoxy mycolic acid (natural cis ... Alfa mycolic acid (natural cis cyclopropyl) - 500 ug. € 295,00. Alfa mycolic acid (natural cis cyclopropyl) quantity. ...
Mycolic acid is the cell wall that contains α-alkylated β-hydroxylated fatty acids present in Mycobacteria, Nocardia, and ... Examples of Mycolic acid biosynthesis inhibitors. *Isoniazid, Ethionamide, etc are some mycolic acid synthesis inhibitors. ... Mechanism of action of Mycolic acid biosynthesis inhibitors*Examples of Mycolic acid biosynthesis inhibitors ... Mycolic acid is the cell wall that contains α-alkylated β-hydroxylated fatty acids present in Mycobacteria, Nocardia, and ...
"The mycolic acids of Mycobacterium chitae",. abstract = "Two-dimensional thin-layer chromatography of whole-organism acid ... The mycolic acids of Mycobacterium chitae. / Ausina, V.; Luquin, M.; Margarit, L. In: Journal of General Microbiology, Vol. 131 ... Ausina, V., Luquin, M., & Margarit, L. (1985). The mycolic acids of Mycobacterium chitae. Journal of General Microbiology, 131( ... Ausina, V. ; Luquin, M. ; Margarit, L. / The mycolic acids of Mycobacterium chitae. In: Journal of General Microbiology. 1985 ...
"The mycolic acids of Mycobacterium chitae",. abstract = "Two-dimensional thin-layer chromatography of whole-organism acid ... The mycolic acids of Mycobacterium chitae. / Ausina, V.; Luquin, M.; Margarit, L. In: Journal of General Microbiology, Vol. 131 ... Ausina, V., Luquin, M., & Margarit, L. (1985). The mycolic acids of Mycobacterium chitae. Journal of General Microbiology, 131( ... Ausina, V. ; Luquin, M. ; Margarit, L. / The mycolic acids of Mycobacterium chitae. In: Journal of General Microbiology. 1985 ...
... and acid stress.[76] Dietary carbohydrates can cause a dramatic decrease in pH in oral biofilms to values of 4 and below (acid ... "The formation apurinic acid from the desoxyribonucleic acid of calf thymus". The Journal of Biological Chemistry. 195 (1): 49- ... Evidence has shown that a fatty acid messenger, cis-2-decenoic acid, is capable of inducing dispersion and inhibiting growth of ... The EPS matrix consists of exopolysaccharides, proteins and nucleic acids.[40][41][42] A large proportion of the EPS is more or ...
Mycobacterium, mycolic acid, reductase, dehydrogenase, tuberculosis. Divisions:. Faculty of Science and Health. Faculty of ... The mycolic acid reductase Rv2509 has distinct structural motifs and is essential for growth in slow growing mycobacteria ... The final step in mycolic acid biosynthesis in Mycobacterium tuberculosis is catalysed by a mycolyl reductase encoded by the ... This conditional depletion also led to a reduction of mature mycolic acid production and accumulation of intermediates derived ...
Glycolipids were visualized using anthrone, and mycolic acids were visualized using phosphomolybdic acid. MA mycolic acids, PLs ... Daffé M, Quémard A, Marrakchi H. Mycolic acids: from chemistry to biology. In: Geiger O, editors. Biogenesis of fatty acids, ... To extract total mycolic acids, MVs and cells were freeze-dried and then incubated with 2.8 mL ethylene glycol monomethyl ether ... Nishiuchi Y, Baba T, Yano I. Mycolic acids from Rhodococcus, Gordonia, and Dietzia. J Microbiol Methods. 2000;40:1-9. ...
Drugs that Inhibit Mycolic Acid Biosynthesis in Mycobacterium tuberculosis. Journal: Current Pharmaceutical Biotechnology. ...
First line drug for TB • Active only againt growing cells • Inhibit mycolic acid synthesis ... Inhibition of Pteroic acid sythetase. 3.1.1. Sulphonamides. 3.1.1.1. are structural analogues to PABA. They competitively ... 2.1.1.1.1. First: [little used Carcinogenic] Nalidixic acid - Cinoxacin • G- [not Pseudomonas] • Uncomplicated urinary tract ... inhibit the incorporation of PABA into Dihydropteroic acid synthesis.. 3.2. Inhibition of dihydrofolate reductase. 3.2.1. ...
The enzyme from Mycobacterium tuberculosis (InhA) promotes the synthesis of long-chain fatty acids, namely mycolic acids, which ... Phosphorylation of InhA inhibits mycolic acid biosynthesis and growth of Mycobacterium tuberculosis. Mol. Microbiol. 2010, 78, ... Nucleic Acids Res. 2008, 36, W223-W228. [Google Scholar] [CrossRef] [PubMed]. *Van Drie, J.H.; Weininger, D.; Martin, Y.C. ... Nucleic Acids Res. 2007, 35, D198-D201. [Google Scholar] [CrossRef] [PubMed]. *Akdemir, A.; Rucktooa, P.; Jongejan, A.; van Elk ...
The bacterium synthesizes mycolic acids, very long chain α-alkyl, β-hydroxyl fatty acids, in three different classes that ... The three mycolic acids includ α-, methoxy-, and keto-mycolates (35,43). The resident cyclopropane rings and methyl branches ... The cyclopropane moiety of mycolic acids is a unique lipid structure that greatly affects the pathogenesis of M. tuberculosis ( ... Huang, C.C.; Smith, C.V.; Glickman, M.S.; Jacobs, W.R.Jr.; Sacchettini, J.C. (2002). Crystal structures of mycolic acid ...
Mycolic acid Long Chain ACP-Enoyl Fatty Acid Reductase (inhA) First-line drugs Rifampicin Rimactan Broad spectrum antibiotic ... p-Aminosalicylic acid Cycloserine Isolated Spreptomyces sp Mech. ≈ Isoniazide PABA antimetabolite Folic acid synth (≈antibact. ... 2 D-lactic acids and 2-D-phenyllactic acids arranged as a cyclic octadepsipeptide with an alternating L-D-L-configuration ... cyanide / hydrocyanic acid (HCN) / prussic acid ==mt rhodanese / thiosulfate sulfurtransferase==> thiocyanate. Therapy for ...
... a novel fatty acid synthase type II protein, is essential for alpha- and epoxy-mycolic acid biosynthesis and mycobacterial ... Le et al. (2020) The protein kinase PknB negatively regulates biosynthesis and trafficking of mycolic acids in mycobacteria. J ... Jamet, S., Quentin, Y., Coudray, C., Texier, P., Laval, F., Daffé, M., Fichant, G., Cam, K. (2015). Evolution of Mycolic Acid ... Marrakchi, H., Lanéelle, M.-A., Daffé, M. (2014). Mycolic acids: Structures, biosynthesis, and beyond. Chemistry & Biology 21, ...
c.66.1.18: Mycolic acid cyclopropane synthase [69560] (7 proteins). *. c.66.1.19: Histamine methyltransferase [75261] (1 ... Nucleic Acids Research 42:D304-309. doi: 10.1093/nar/gkt1240. Chandonia JM, Guan L, Lin S, Yu C, Fox NK, Brenner SE. 2022. ... Nucleic Acids Research 50:D553-559. doi: 10.1093/nar/gkab1054. (citing information) Copyright © 1994-2023 The SCOP and SCOPe ... c.66.1.35: Salicylic acid carboxyl methyltransferase (SAMT) [102563] (1 protein). automatically mapped to Pfam PF03492. ...
Mycolic acids were not detected. The diagnostic phospholipid was phosphatidylethanolamine. The predominant cellular fatty acids ... The cell-wall peptidoglycan contained meso-diaminopimelic acid, glutamic acid and alanine as cell-wall amino acids; whole-cell ... The major fatty acids (>10 % of total fatty acids) were iso-C15 : 0, iso-C17 : 0 and anteiso-C15 : 0. The DNA G+C content of ... The diagnostic diamino acid in the cell wall was ll-diaminopimelic acid. The predominant menaquinone was MK-8(H4). The polar ...
Using Isoniazide prevents the synthesis of mycolic acid, one of the constituents of the cell wall.. 2) M. tuberculosis ... With regards to pyrazinamide, these individuals may get high uric acid levels and resulting arthralgias. They can even get ...
... routinely diagnosed in biopsies from the small intestine and other tissues by periodic acid-Schiff (PAS) diastase staining and ... routinely diagnosed in biopsies from the small intestine and other tissues by periodic acid-Schiff (PAS)-diastase staining and ... Improved permeabilization protocols for fluorescence in situ hybridization (FISH) of mycolic-acid-containing bacteria found in ... Quantitative use of fluorescent in situ hybridization to examine relationships between mycolic acid-containing actinomycetes ...
Mycolic Acid 9% * Bubbling 7% * Protein Folding 6% * Cell Death 6% * Liposome 5% ...
New Approaches to Target the Mycolic Acid Biosynthesis Pathway for the Development of Tuberculosis Therapeutics. Curr Pharm Des ... Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane. Nat Chem Biol February 19, 2012. ... New β-lactam - Tetramic acid hybrids show promising antibacterial activities. Bioorg Med Chem Lett Oct 1;28(18):3105-3112, 2018 ...
of mycolic acids, contributing to its potential to become resistant to certain antibiotics. This can make treating TB difficult ...
... known as mycolic acid), the usual stains for looking at bacteria with a microscope do not work. The mycolic acids give the ... The special stain is called an acid-fast stain. The stain causes the Mycobacterium to look like very small red rods that are ... The rest of the sample is transferred to culture (growth) media which will allow any acid-fast bacilli which are present to ...
This ability is attributed to a waxlike layer composed of long-chain fatty acids, the mycolic acids, in their cell wall. As a ... Acid-fast bacilli appear as yellow-green fluorescent thin rods against a dark background. Courtesy of Robert Schelper, MD, ... However, Ziehl-Neelsen stain forms a complex in the cell wall that prevents decolorization by acid or alcohol, and the bacilli ... After decolorization with an acid-alcohol preparation, the smear is counterstained with acridine orange or thiazine red and ...
... to detect the species-specific mycolic acids produced by those genera that contain these unique fatty acids. For the genus ... capillary gas chromatography has been used to study the short-chain fatty acids and cleavage products of mycolic acids from ... each of the species examined to date has its own unique mycolic acid pattern. When used on primary culture isolates, this ... The detection of acid-fast bacilli in stained smears examined microscopically is the first bacteriologic evidence of the ...
  • Mycolic acids are long fatty acids found in the cell walls of the Mycolata taxon, a group of bacteria that includes Mycobacterium tuberculosis, the causative agent of the disease tuberculosis. (wikipedia.org)
  • Mycolic acids are the main component of the cell wall of Mycobacterium spp and plays important role in the virulence and permeability of the outer membrane. (microbenotes.com)
  • Two-dimensional thin-layer chromatography of whole-organism acid methanolysates of Mycobacterium chitae gives a characteristic pattern composed of a α-mycolate, a lower molecular weight α'-mycolate and characteristic pairs of polar mycolates. (url.edu)
  • This pattern of mycolic acids has only been found previously in representatives of Mycobacterium farcinogenes, Mycobacterium fortuitum, 'Mycobacterium peregrinum', Mycobacterium senegalense and Mycobacterium smegmatis. (url.edu)
  • The final step in mycolic acid biosynthesis in Mycobacterium tuberculosis is catalysed by a mycolyl reductase encoded by the Rv2509 gene. (essex.ac.uk)
  • Recently, some specific Gram-positive bacteria, including Mycobacterium tuberculosis and Corynebacterium glutamicum , were found to possess a novel cell wall structure consisting of an arabinogalactan layer covalently linked to the peptidoglycan layer, and a special outer membrane consisting of mycolic acids (mycomembrane) [ 19 ]. (nature.com)
  • The carboxyl group of mycolic acids is vertically covalently linked to the hydroxyl group of arabino-galactan by ester bond, arabino-galactan is linked to the peptidoglycan layer by phospholipid bond, whereas other glycolipids and free lipids are regularly distributed in the thicker layer of mycolic acids [ 3 , 4 , 5 ]. (biomedcentral.com)
  • As an important intermediate metabolite, acetyl-coA not only participates in tricarboxylic acid cycle as well as the glyoxylate cycle but also provides carbon source for the synthesis of mycolic acid and lipids [ 8 , 9 ]. (biomedcentral.com)
  • and Transfer of mycolic acids to arabinogalactan and other acceptors such as trehalose via the antigen 85 complex The fatty acid synthase-I and fatty acid synthase-II pathways producing mycolic acids are linked by the beta-ketoacyl-(acyl-carrier-protein) synthase III enzyme, often designated as mtFabH. (wikipedia.org)
  • Mycolic acids are a class of long chain α-alkyl-β-hydroxy fatty acids which constitute a significant part of the outer membrane bilayer of Mycobacteria. (lipidknowledge.com)
  • Mycolic acid is the cell wall that contains α-alkylated β-hydroxylated fatty acids present in Mycobacteria, Nocardia, and Corynebacteria . (microbenotes.com)
  • The formation of 3-hydroxy C18, C20, and C22 fatty acids shows the inhibition of the dehydratase step in the fatty acid synthase II elongation cycle. (microbenotes.com)
  • Sequence analysis and homology modelling indicates that Rv2509 belongs to the short‐chain fatty acid dehydrogenase/reductase (SDR) family, but with some distinct features that warrant its classification as belonging to a novel family of short‐chain dehydrogenases. (essex.ac.uk)
  • These structures are unusual because the common extracellular matrix is made out of long chains of fatty acids. (pharmexec.com)
  • Mycobacteria normally produce very long fatty acids with 60 to 90 carbons, called mycolic acids, Hatfull explained. (pharmexec.com)
  • When mycobacteria form biofilms they produce shorter chains of fatty acids, 58 to 68 carbons in length, Hatfull said. (pharmexec.com)
  • These fatty acids may be involved in creating the encompassing matrix, he added. (pharmexec.com)
  • According to Jacobs, groEL1 is probably involved in processing proteins that are essential for switching to the shorter fatty acid chains, KasA and KasB. (pharmexec.com)
  • As a result he speculated that these two proteins were not able to get into their proper formations for fatty acid synthesis without the help of groEL1. (pharmexec.com)
  • The leading TB drug, Nydrazid or Laniazid (isoniazid), inhibits the synthesis of the longer chains of fatty acids that are part of the tuberculosis bacterial cell wall, Hatfull said. (pharmexec.com)
  • The organism is surrounded by a dense waxy coat consisting of unusual long-chain fatty acids (mycolipids) with hydroxyl, methyl, and cyclopropyl substitutions that prevent many common antibiotics from entering the cell [ 2 ]. (biomedcentral.com)
  • DNA probes and mycolic acids high-pressure liquid chromatography performed on a culture from a clinical specimen) are acceptable under this criterion. (cdc.gov)
  • Mycolic acids impart M. tuberculosis with unique properties that defy medical treatment. (wikipedia.org)
  • An international multi-centre study has proved that delamanid (OPC-67683), a new agent derived from the nitro-dihydro-imidazooxazole class of compounds that inhibits mycolic acid synthesis, can increase the rate of sputum culture conversion in multi-drug-resistant tuberculosis (MDRTB) at 2 months. (wikipedia.org)
  • The mycolic acids of members of the genus Rhodococcus, another member of the mycolata taxon, differ in several ways from those of M. tuberculosis. (wikipedia.org)
  • M. tuberculosis has a unique cell wall structure composed of mycolic acids, contributing to its potential to become resistant to certain antibiotics . (medicalnewstoday.com)
  • First discovered in 1882 by Robert Koch, M. tuberculosis has an unusual, waxy coating on its cell surface primarily due to the presence of mycolic acid. (kembrel.com)
  • Further, individuals with mutations in genes responsible for mycolic acid synthesis exhibit altered cording. (wikipedia.org)
  • Over all, this study indicates that aceE gene plays a significant role in the mycolic acid synthesis and affects the colony morphology, biofilm formation of M. smegmatis and bacteria invasion of macrophage. (biomedcentral.com)
  • Inhibition of mycolic acid synthesis by isoniazid and pyridomycin. (microbenotes.com)
  • The main effect shown by isoxyl is inhibition of synthesis of tuberculostearic and oleic acid which is directly related to the effect shown by a drug. (microbenotes.com)
  • It is a weak antitubercular drug and it inhibits bacteria by mycolic acid cyclopropane synthesis. (microbenotes.com)
  • Isoniazid, Ethionamide, etc are some mycolic acid synthesis inhibitors. (microbenotes.com)
  • Using Isoniazide prevents the synthesis of mycolic acid, one of the constituents of the cell wall. (khanacademy.org)
  • Alpha-mycolic acids make up at least 70% of the mycolic acids of the organism and contain several cyclopropane rings. (wikipedia.org)
  • Mycolic acids have various functions and are vital for the survival and pathogenesis of mycobacteria. (lipidknowledge.com)
  • The Mycobacteria genus, member of the Mycobacteriacea family and Actinomycetales order, are nonmotile, nonsporulating, acid-fast bacilli, 2-4 μ in length and 0.2-0.5 μ in width. (benthamscience.com)
  • One defining feature of most atypical mycobacteria is that they are acid-fast bacilli. (statpearls.com)
  • HNucleic acid amplification (NAA) tests must be accompanied by culture for mycobacteria species. (cdc.gov)
  • A pilot study of a novel ELISA test using synthetic mycolic acid antigens for serodiagnosis of nontuberculous mycobacterial infections. (ers-education.org)
  • The energy released from breaking the peptide bond between the two alanines is used in the formation of a new peptide bond between the remaining D-alanine on the stem peptide and a free amino group present on the third amino acid of the stem peptides in the existing cross-linked peptidoglycan. (pharmacy180.com)
  • Based on product type, the market is segmented into cell wall inhibitors, protein inhibitors, DNA and other inhibitors (RNA, mycolic acid, folic acid). (bharatbook.com)
  • Whole-cell hydrolysates of strain TÜ4103T are rich in meso-diaminopimelic acid, and rhamnose, galactose and mannose are characteristic as whole-cell sugars. (bvsalud.org)
  • Methoxy-mycolic acids, which contain several methoxy groups, constitute between 10% and 15% of the mycolic acids in the organism. (wikipedia.org)
  • TheTag7 protein consists of 182 amino acids. (embl-heidelberg.de)
  • In many organisms, including E. coli, this acceptor amino group is supplied by the amino acid diaminopimelic acid. (pharmacy180.com)
  • aureus, the acceptor amino group is supplied by the amino acid l-lysine. (pharmacy180.com)
  • Both enzymes retained all amino acids known to be involved in catalysing the reaction. (biomedcentral.com)
  • Our results suggest that the alteration of the mycolic acid and phospholipid membrane composition may be a strategy of R. opacus for phenol tolerance. (biomedcentral.com)
  • In addition, the genome codes for the meso-diaminopimelic acid which is incorporated within the cell wall [4]. (kenyon.edu)
  • Extraction of the mycolic acids, followed by HPLC separation and mass spectrometry detection. (mirri.org)
  • CoAg PHL utilize a variety of NAAT algorithms with the most common described as testing of new acid fast bacilli (AFB) smear positive specimens and when requested, those that are AFB smear negative. (cdc.gov)
  • Acid-fast bacilli (AFB) smear and culture using sputum obtained from the patient. (medscape.com)
  • The exact structure of mycolic acids appears to be closely linked to the virulence of the organism, as modification of the functional groups of the molecule can lead to an attenuation of growth in vivo. (wikipedia.org)
  • Data in this TB Laboratory Aggregate Report--Fifth Edition include a comparison of aggregate workload data and nucleic acid amplification test (NAAT) trends for calendar years 2015, 2016, and 2017. (cdc.gov)
  • Nucleic acid amplification test. (cdc.gov)
  • Depicted in this 2007 photograph was former Centers for Disease Control and Prevention (CDC), Microbiologist, Ray Butler (background), and fellow Microbiologist, Sean Toney, who were in the process of verifying mycolic acid samples that would be used for species identification. (cdc.gov)
  • This staining property detected via the Kinyoun method is due to its hydrophobic mycolic acid outer layer. (statpearls.com)
  • Disrupting the mycolic acid pathway with the help of effective treatment is a great task and proven therapy by the drugs like isoniazid, ethionamide, isoxyl, thiacteazone, and triclosan. (microbenotes.com)
  • It acts similar to isoniazid is a nicotinic acid derivative that undergoes intracellular alteration. (microbenotes.com)
  • Their waxy cell wall, rich in mycolic acid plays an important role in its resistance to many antibiotics. (benthamscience.com)
  • This mycolic acid layer allows them to form thick biofilms, enabling their survival in harsh environments that are not as well tolerated by other bacteria. (statpearls.com)
  • Analysis of alkaline methanolysates confirmed that these polar mycolates were derived from epoxymycolic acids. (url.edu)
  • Mycolic acids also allow the bacterium to grow inside macrophages, effectively hiding it from the host immune system. (wikipedia.org)
  • Through a series of chemical reactions of pyruvate decarboxylation, the glycolytic pathway (the final product is pyruvate) and the tricarboxylic acid cycle (the initial reactant is acetyl-coA) can be effectively connected [ 7 ]. (biomedcentral.com)
  • Sputum distributed in Far Eastern countries, Acari and emerging/reemerging infectious was 3+ smear positive for acid-fast diseases [in Japanese]. (cdc.gov)
  • In both strains, mycolic acids had fewer double bond numbers in phenol conditions than the glucose condition, and evol40 had significantly shorter mycolic acid chain lengths than the WT strain in phenol conditions. (biomedcentral.com)
  • Mycolic acids are composed of a longer beta-hydroxy chain with a shorter alpha-alkyl side chain. (wikipedia.org)
  • The analysis of mycolic acid (MA) using LC-MS indicated deficiency of alpha-MA and epoxy-MA in aceE -mut strain whereas complementation of the aceE -mut with a wild-type aceE gene restored the composition of MA. (biomedcentral.com)
  • L'enveloppe mycobactérienne est unique dans le monde bactérien, tant par sa composition riche en composés structurellement exotiques, que par son agencement, avec notamment la présence d'une membrane externe et d'une membrane interne. (ipbs.fr)
  • These results indicate that phenol adaptation affected mycolic acid membrane composition. (biomedcentral.com)
  • Whipple's disease (WD) is a rare chronic systemic infection with a wide range of clinical symptoms, routinely diagnosed in biopsies from the small intestine and other tissues by periodic acid-Schiff (PAS) diastase staining and immunohistological analysis with specific antibodies. (frontiersin.org)
  • This conditional depletion also led to a reduction of mature mycolic acid production and accumulation of intermediates derived from 3‐oxo‐mycolate precursors. (essex.ac.uk)